TOMBAK, A. Et Al. 2021. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data. TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4 , 273-285.

TOMBAK, A., Tanrikulu, F. P., Durusoy, S. S., DİNÇYÜREK, H. D., KAYA, E., ÜMİT, E. G., ... YAVAŞOĞLU, İ.(2021). Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data. TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4, 273-285.

TOMBAK, ANIL Et Al. "Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data," TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4, 273-285, 2021

TOMBAK, ANIL Et Al. "Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data." TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4, pp.273-285, 2021

TOMBAK, A. Et Al. (2021) . "Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data." TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4, pp.273-285.

@article{article, author={ANIL TOMBAK Et Al. }, title={Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2021, pages={273-285} }